SI1639013T1 - Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji - Google Patents
Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapijiInfo
- Publication number
- SI1639013T1 SI1639013T1 SI200431971T SI200431971T SI1639013T1 SI 1639013 T1 SI1639013 T1 SI 1639013T1 SI 200431971 T SI200431971 T SI 200431971T SI 200431971 T SI200431971 T SI 200431971T SI 1639013 T1 SI1639013 T1 SI 1639013T1
- Authority
- SI
- Slovenia
- Prior art keywords
- kir2dl
- pan
- diagnostic
- therapy
- receptor antibodies
- Prior art date
Links
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48389403P | 2003-07-02 | 2003-07-02 | |
US54547104P | 2004-02-19 | 2004-02-19 | |
EP04744115A EP1639013B1 (en) | 2003-07-02 | 2004-07-01 | Pan-kir2dl NK-receptor antibodies and their use in diagnostic and therapy |
PCT/IB2004/002464 WO2005003172A2 (en) | 2003-07-02 | 2004-07-01 | Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1639013T1 true SI1639013T1 (sl) | 2013-01-31 |
Family
ID=37031117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200431971T SI1639013T1 (sl) | 2003-07-02 | 2004-07-01 | Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji |
Country Status (4)
Country | Link |
---|---|
CN (2) | CN1852924A (sl) |
ES (1) | ES2358078T3 (sl) |
SI (1) | SI1639013T1 (sl) |
ZA (2) | ZA200600792B (sl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008084106A1 (en) * | 2007-01-11 | 2008-07-17 | Novo Nordisk A/S | Anti-kir antibodies, formulations, and uses thereof |
CN101804193B (zh) * | 2009-02-16 | 2012-09-26 | 重庆西南医院 | CTLA4Ig及其衍生物用于抗病毒 |
WO2010091542A1 (zh) * | 2009-02-16 | 2010-08-19 | 重庆西南医院 | Ctla4ig及其衍生物的抗肿瘤、抗细菌和/或抗病毒应用 |
EP2625188A4 (en) * | 2010-10-06 | 2014-05-07 | St Jude Childrens Res Hospital | DETERMINANT-BASED MOLECULAR TYPISATION OF KIR ALLELES AND KIR LIGANDS |
AR083957A1 (es) * | 2010-11-22 | 2013-04-10 | Innate Pharma Sa | Tratamiento para modular las celulas nk y metodos para tratar malignidad hematologica |
EA036545B1 (ru) * | 2011-05-25 | 2020-11-20 | Иннейт Фарма, С.А. | Анти-kir антитела для лечения воспалительных заболеваний |
CN104914242B (zh) * | 2014-09-29 | 2017-08-11 | 深圳华大基因科技服务有限公司 | 用于癌症诊断和治疗的方法和组合物 |
-
2004
- 2004-07-01 SI SI200431971T patent/SI1639013T1/sl unknown
- 2004-07-01 ES ES04738967T patent/ES2358078T3/es not_active Expired - Lifetime
- 2004-07-01 CN CN 200480024006 patent/CN1852924A/zh active Pending
- 2004-07-01 CN CN2004800218970A patent/CN1842541B/zh not_active Expired - Lifetime
-
2006
- 2006-01-27 ZA ZA200600792A patent/ZA200600792B/en unknown
- 2006-01-30 ZA ZA200600842A patent/ZA200600842B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2358078T3 (es) | 2011-05-05 |
CN1842541A (zh) | 2006-10-04 |
ZA200600842B (en) | 2007-04-25 |
CN1842541B (zh) | 2013-03-27 |
CN1852924A (zh) | 2006-10-25 |
ZA200600792B (en) | 2007-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL172316A0 (en) | Novel compounds and their use in therapy | |
HK1081448A1 (en) | Bispecific anti-erb-b antibodies and their use in tumor therapy | |
SI2287195T1 (sl) | Pan-kir2dl nk-receptor protitelesa in njihova uporaba pri diagnostiki in terapiji | |
IL174994A0 (en) | Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy | |
IL163563A (en) | Anti-amyloid beta antibodies and their use in medicine | |
IL190332A0 (en) | Human antibodies against il13 and therapeutic uses | |
GB0418542D0 (en) | Integrated biosensor and simulation system for diagnosis and therapy | |
AU2003278807A8 (en) | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy | |
EP2014310B8 (en) | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy | |
IL182652A0 (en) | Nitrobenzindoles and their use in cancer therapy | |
EP1781685A4 (en) | THERAPEUTIC AND DIAGNOSTIC AGENTS | |
EP1572741A4 (en) | DIAGNOSTIC AND THERAPEUTIC AGENTS | |
AU2003227148A8 (en) | Anti-ck18 monoclonal antibody and therapeutic and diagnostic uses thereof in cancer | |
GB0303663D0 (en) | Assays and medical treatments | |
GB0308382D0 (en) | Therapeutic methods and means | |
SI1639013T1 (sl) | Pan-kir2dl nk-receptorska protitelesca in njihova uporaba pri diagnosticiranju in terapiji | |
GB0326578D0 (en) | Cancer diagnosis and therapy | |
SG110107A1 (en) | Compound and use in treatment | |
AU2003245858A8 (en) | Uses of ngal-binding substances in the diagnosis and treatment of cancer diseases | |
GB0318546D0 (en) | Quinoxalinones and their use | |
EP1666046A4 (en) | USE OF N-ACETYL-D-AMINOGLYCOSAMINE FOR THE PREPARATION OF DRUGS FOR THE TREATMENT OF CANCER AND METASTASES | |
AU2003209459A8 (en) | Protein-protein interactions in human tumours involving bcmp-7 and bcmp-11 | |
ZA200802541B (en) | Human antibodies against IL13 and therapeutic uses | |
GB0424871D0 (en) | Antibodies and their use in therapy | |
GB0505908D0 (en) | Antibodies and their use in therapy |